The University of Chicago Header Logo

Connection

Anand Patel to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Anand Patel has written about Drug Administration Schedule.
Anand Patel
Connection Strength
0.041
Drug Administration Schedule
  1. Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. Cancer. 2021 04 01; 127(7):1039-1048.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.